Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Multicenter, Double-Blind, Randomized, Crossover Design Study to Evaluate the Effect of Montelukast Vs. Salmeterol on the Inhibition of Exercise-Induced Bronchoconstriction in Asthmatic Patients Aged 6-14 Years
Brief Summary: The purpose of this study is to determine the effect of four weeks of treatment with two investigational drugs (oral versus inhaled administration) plus an inhaled medication in the treatment of airway constriction brought on by exercise in participants with asthma.


Options:
A: Intervention Type: BEHAVIORAL; Name: Shared Decision-Making; Assigned to Arm(s): N/A
B: Arm Label: Fluticasone Propionate/Salmeterol/Montelukast (FSC+MON); Type: ACTIVE_COMPARATOR; Interventions: Drug: fluticasone propionate/salmeterol (FSC), Drug: montelukast (MON), Drug: placebo nasal, Drug: ADVAIR DISKUS | Arm Label: Fluticasone Propionate/Salmeterol (FSC); Type: ACTIVE_COMPARATOR; Interventions: Drug: fluticasone propionate/salmeterol (FSC), Drug: placebo nasal, Drug: ADVAIR DISKUS, Drug: placebo capsule | Arm Label: Fluticasone Prop/Salmeterol/Flut Prop Nasal Spray (FSC+FPANS); Type: ACTIVE_COMPARATOR; Interventions: Drug: fluticasone propionate/salmeterol (FSC), Drug: fluticasone propionate (FP), Drug: ADVAIR DISKUS, Drug: placebo capsule | Arm Label: Montelukast (MON); Type: ACTIVE_COMPARATOR; Interventions: Drug: montelukast (MON), Drug: placebo nasal, Drug: placebo DISKUS | Intervention Type: DRUG; Name: fluticasone propionate/salmeterol (FSC); Assigned to Arm(s): Fluticasone Prop/Salmeterol/Flut Prop Nasal Spray (FSC+FPANS), Fluticasone Propionate/Salmeterol (FSC), Fluticasone Propionate/Salmeterol/Montelukast (FSC+MON) | Intervention Type: DRUG; Name: montelukast (MON); Assigned to Arm(s): Fluticasone Propionate/Salmeterol/Montelukast (FSC+MON), Montelukast (MON) | Intervention Type: DRUG; Name: fluticasone propionate (FP); Assigned to Arm(s): Fluticasone Prop/Salmeterol/Flut Prop Nasal Spray (FSC+FPANS) | Intervention Type: DRUG; Name: placebo nasal; Assigned to Arm(s): Fluticasone Propionate/Salmeterol (FSC), Fluticasone Propionate/Salmeterol/Montelukast (FSC+MON), Montelukast (MON) | Intervention Type: DRUG; Name: ADVAIR DISKUS; Assigned to Arm(s): Fluticasone Prop/Salmeterol/Flut Prop Nasal Spray (FSC+FPANS), Fluticasone Propionate/Salmeterol (FSC), Fluticasone Propionate/Salmeterol/Montelukast (FSC+MON) | Intervention Type: DRUG; Name: placebo capsule; Assigned to Arm(s): Fluticasone Prop/Salmeterol/Flut Prop Nasal Spray (FSC+FPANS), Fluticasone Propionate/Salmeterol (FSC) | Intervention Type: DRUG; Name: placebo DISKUS; Assigned to Arm(s): Montelukast (MON)
C: Arm Label: Montelukast/Salmeterol; Type: EXPERIMENTAL; Interventions: Drug: Montelukast sodium, Drug: Salmeterol xinafoate, Drug: Fluticasone propionate, Drug: Montelukast matching placebo, Drug: Salmeterol matching placebo | Arm Label: Salmeterol/Montelukast; Type: EXPERIMENTAL; Interventions: Drug: Montelukast sodium, Drug: Salmeterol xinafoate, Drug: Fluticasone propionate, Drug: Montelukast matching placebo, Drug: Salmeterol matching placebo | Intervention Type: DRUG; Name: Montelukast sodium; Assigned to Arm(s): Montelukast/Salmeterol, Salmeterol/Montelukast | Intervention Type: DRUG; Name: Salmeterol xinafoate; Assigned to Arm(s): Montelukast/Salmeterol, Salmeterol/Montelukast | Intervention Type: DRUG; Name: Fluticasone propionate; Assigned to Arm(s): Montelukast/Salmeterol, Salmeterol/Montelukast | Intervention Type: DRUG; Name: Montelukast matching placebo; Assigned to Arm(s): Montelukast/Salmeterol, Salmeterol/Montelukast | Intervention Type: DRUG; Name: Salmeterol matching placebo; Assigned to Arm(s): Montelukast/Salmeterol, Salmeterol/Montelukast
D: Arm Label: Placebo pill; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Arm Label: Singular pill; Type: EXPERIMENTAL; Interventions: Drug: singular | Intervention Type: DRUG; Name: singular; Assigned to Arm(s): Singular pill | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Placebo pill

Answer: C